Filing Flows › Novo Nordisk A S (NVO) › Net income
Novo Nordisk A S (NVO) net income by quarter
Novo Nordisk A S' net income was $16.7B in Q3 2026 (third quarter 2026), -20% from Q2 2026. Over the last 6 quarters it ranged from $16.7B (Q3 2026) to $48.6B (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.7B | -20% | -16% |
| Q2 2026 | $21.0B | -57% | -21% |
| Q1 2026 | $48.6B | +81% | — |
| Q4 2025 | $26.9B | +34% | — |
| Q3 2025 | $20.0B | -25% | — |
| Q2 2025 | $26.5B | — | — |
Q3 2026 at a glance
Novo Nordisk A S, Q3 2026: revenue $79.2B (+6% year over year), operating margin 29.1%, net earnings $16.7B, operating cash flow $41.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novo Nordisk A S' net income?
Novo Nordisk A S' net income was $16.7B in Q3 2026 (third quarter 2026), -20% from Q2 2026.
How has Novo Nordisk A S' net income changed?
Over the last 6 quarters it ranged from $16.7B (Q3 2026) to $48.6B (Q1 2026).